Phase II and pharmacokinetic study of CPT-11 [irinotecan] and trastuzumab (RhuMab HER2, Herceptin) in advanced colo-rectal cancer with p185 HER 2 overexpression
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2013
At a glance
- Drugs Irinotecan (Primary) ; Trastuzumab (Primary)
- Indications Colorectal cancer
- Focus Pharmacokinetics; Therapeutic Use
- 07 Feb 2013 Actual end date added as 1 Mar 2006 as reported by ClinicalTrials.gov record.
- 11 Jan 2007 Status changed from in progress to completed
- 15 Sep 2005 New trial record.